These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 25157354)

  • 1. Patients with poor response to antipsychotics have a more severe pattern of frontal atrophy: a voxel-based morphometry study of treatment resistance in schizophrenia.
    Quarantelli M; Palladino O; Prinster A; Schiavone V; Carotenuto B; Brunetti A; Marsili A; Casiello M; Muscettola G; Salvatore M; de Bartolomeis A
    Biomed Res Int; 2014; 2014():325052. PubMed ID: 25157354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gray matter volume changes following antipsychotic therapy in first-episode schizophrenia patients: A longitudinal voxel-based morphometric study.
    Guo F; Zhu YQ; Li C; Wang XR; Wang HN; Liu WM; Wang LX; Tian P; Kang XW; Cui LB; Xi YB; Yin H
    J Psychiatr Res; 2019 Sep; 116():126-132. PubMed ID: 31233895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain morphometry of individuals with schizophrenia with and without antipsychotic medication – The Northern Finland Birth Cohort 1966 Study.
    Moilanen J; Huhtaniska S; Haapea M; Jääskeläinen E; Veijola J; Isohanni M; Koponen H; Miettunen J
    Eur Psychiatry; 2015 Jul; 30(5):598-605. PubMed ID: 25791180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional change in brain morphometry in schizophrenia associated with antipsychotic treatment.
    McClure RK; Phillips I; Jazayerli R; Barnett A; Coppola R; Weinberger DR
    Psychiatry Res; 2006 Dec; 148(2-3):121-32. PubMed ID: 17097276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extensive gray matter volume reduction in treatment-resistant schizophrenia.
    Anderson VM; Goldstein ME; Kydd RR; Russell BR
    Int J Neuropsychopharmacol; 2015 Feb; 18(7):pyv016. PubMed ID: 25716781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common pattern of gray-matter abnormalities in drug-naive and medicated first-episode schizophrenia: a multimodal meta-analysis.
    Shah C; Zhang W; Xiao Y; Yao L; Zhao Y; Gao X; Liu L; Liu J; Li S; Tao B; Yan Z; Fu Y; Gong Q; Lui S
    Psychol Med; 2017 Feb; 47(3):401-413. PubMed ID: 27776571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive Grey Matter Volume Changes in Patients with Schizophrenia over 6 Weeks of Antipsychotic Treatment and Their Relationship to Clinical Improvement.
    Zhang X; Zhang Y; Liao J; Jiang S; Yan J; Yue W; Zhang D; Yan H
    Neurosci Bull; 2018 Oct; 34(5):816-826. PubMed ID: 29779085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focal gray matter changes in schizophrenia across the course of the illness: a 5-year follow-up study.
    van Haren NE; Hulshoff Pol HE; Schnack HG; Cahn W; Mandl RC; Collins DL; Evans AC; Kahn RS
    Neuropsychopharmacology; 2007 Oct; 32(10):2057-66. PubMed ID: 17327887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional Abnormality of Grey Matter in Schizophrenia: Effect from the Illness or Treatment?
    Yue Y; Kong L; Wang J; Li C; Tan L; Su H; Xu Y
    PLoS One; 2016; 11(1):e0147204. PubMed ID: 26789520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased grey matter densities in schizophrenia patients with negative symptoms after treatment with quetiapine: a voxel-based morphometry study.
    Stip E; Mancini-Marïe A; Letourneau G; Fahim C; Mensour B; Crivello F; Dollfus S
    Int Clin Psychopharmacol; 2009 Jan; 24(1):34-41. PubMed ID: 19077676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortical grey matter volume reduction in people with schizophrenia is associated with neuro-inflammation.
    Zhang Y; Catts VS; Sheedy D; McCrossin T; Kril JJ; Shannon Weickert C
    Transl Psychiatry; 2016 Dec; 6(12):e982. PubMed ID: 27959331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early striatal hypertrophy in first-episode psychosis within 3 weeks of initiating antipsychotic drug treatment.
    Chua SE; Deng Y; Chen EY; Law CW; Chiu CP; Cheung C; Wong JC; Lienenkaëmper N; Cheung V; Suckling J; McAlonan GM
    Psychol Med; 2009 May; 39(5):793-800. PubMed ID: 18713487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural brain changes associated with antipsychotic treatment in schizophrenia as revealed by voxel-based morphometric MRI: an activation likelihood estimation meta-analysis.
    Torres US; Portela-Oliveira E; Borgwardt S; Busatto GF
    BMC Psychiatry; 2013 Dec; 13():342. PubMed ID: 24359128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between brain morphology and outcome in schizophrenia in a general population sample.
    Jääskeläinen E; Juola P; Kurtti J; Haapea M; Kyllönen M; Miettunen J; Tanskanen P; Murray GK; Huhtaniska S; Barnes A; Veijola J; Isohanni M
    Eur Psychiatry; 2014 Sep; 29(7):456-62. PubMed ID: 24342739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gray matter in first-episode schizophrenia before and after antipsychotic drug treatment. Anatomical likelihood estimation meta-analyses with sample size weighting.
    Leung M; Cheung C; Yu K; Yip B; Sham P; Li Q; Chua S; McAlonan G
    Schizophr Bull; 2011 Jan; 37(1):199-211. PubMed ID: 19759093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ECT-induced brain plasticity correlates with positive symptom improvement in schizophrenia by voxel-based morphometry analysis of grey matter.
    Wang J; Tang Y; Curtin A; Xia M; Tang X; Zhao Y; Li Y; Qian Z; Sheng J; Zhang T; Jia Y; Li C; Wang J
    Brain Stimul; 2019; 12(2):319-328. PubMed ID: 30473477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential contributions of prefrontal and temporolimbic pathology to mechanisms of psychosis.
    Suzuki M; Zhou SY; Takahashi T; Hagino H; Kawasaki Y; Niu L; Matsui M; Seto H; Kurachi M
    Brain; 2005 Sep; 128(Pt 9):2109-22. PubMed ID: 15930048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain structural changes associated with chronicity and antipsychotic treatment in schizophrenia.
    Tomelleri L; Jogia J; Perlini C; Bellani M; Ferro A; Rambaldelli G; Tansella M; Frangou S; Brambilla P;
    Eur Neuropsychopharmacol; 2009 Dec; 19(12):835-40. PubMed ID: 19717283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-brain morphometric study of schizophrenia revealing a spatially complex set of focal abnormalities.
    Davatzikos C; Shen D; Gur RC; Wu X; Liu D; Fan Y; Hughett P; Turetsky BI; Gur RE
    Arch Gen Psychiatry; 2005 Nov; 62(11):1218-27. PubMed ID: 16275809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of cerebral deficits with clinical symptoms in antipsychotic-naive first-episode schizophrenia: an optimized voxel-based morphometry and resting state functional connectivity study.
    Lui S; Deng W; Huang X; Jiang L; Ma X; Chen H; Zhang T; Li X; Li D; Zou L; Tang H; Zhou XJ; Mechelli A; Collier DA; Sweeney JA; Li T; Gong Q
    Am J Psychiatry; 2009 Feb; 166(2):196-205. PubMed ID: 18981063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.